CVS Health Stock Forecast for 2022 - 2025 - 2030

Updated on 12/08/2022

Stock Rating
13
Price Target
$118.00
Consensus
Outperform
Upside
15.09%
Analysts
17
Stock Rating
13
Upside
15.09%
Analysts
17
Price Target
$118.00

CVS Health Stock Forecast and Price Target

CVS Health's most recent price target of $118.00 for 2022 was provided by seventeen renowned analysts over the past few months, with an average prediction of $118.00. If this prediction is correct, CVS Health's stock could rise by 15.09 percent from its current trading price. The potential increase for the stock is $118.00 per share, with a possible range of $106.00 to $130.00. If interested in CVS stock, you may also want to consider its competitors.

$118.00

15.09% Upside

Outperform
Outperform

CVS Health Fair Value Forecast for 2022 - 2025 - 2030

In the last three years, CVS Health's Price has grown, moving from $72.78 to $86.35 – an increase of 18.64%. For the next year, 24 analysts project CVS Health's Fair Value to drop by 1.55%, reaching $85.02. Looking ahead to nine years, experts forecast that Fair Value will grow by 86.90%.

2022 Fair Value Forecast
$85.02
2023 Fair Value Forecast
$92.01
2024 Fair Value Forecast
$102.08
2025 Fair Value Forecast
$113.70
2026 Fair Value Forecast
$126.86
2027 Fair Value Forecast
$131.28
2028 Fair Value Forecast
$140.32
2029 Fair Value Forecast
$151.53
2030 Fair Value Forecast
$161.40
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
AMZN Stock Forecast Amazon.com Buy 13
$90.35 Buy/Sell $143.50 54.95%
MCD Stock Forecast McDonald's Outperform 15
$273.39 Buy/Sell $282.36 6.08%
HON Stock Forecast Honeywell International Outperform 10
$213.35 Buy/Sell $207.33 1.71%
SIE Stock Forecast Siemens Outperform 3
132.00€ Buy/Sell 167.08€ 16.86%
MDT Stock Forecast Medtronic Outperform 11
$77.79 Buy/Sell $90.77 11.20%

CVS Health Revenue Forecast for 2022 - 2025 - 2030

In the last three years, CVS Health's Revenue has grown, moving from $193.92B to $290.91B – an increase of 50.02%. In the next year, analysts predict that Revenue will jump to $307.54B – up 5.71% from the current level. Looking ahead to nine years, experts forecast that Revenue will grow by 33.84%.

2022 Rev Forecast
$307.54B
2023 Rev Forecast
$320.76B
2024 Rev Forecast
$336.79B
2025 Rev Forecast
$367.22B
2026 Rev Forecast
$389.91B
2027 Rev Forecast
$363.14B
2028 Rev Forecast
$371.90B
2029 Rev Forecast
$380.65B
2030 Rev Forecast
$389.36B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
CI Stock Forecast Cigna Outperform 13
$333.50 Buy/Sell $295.91 7.05%
TJX Stock Forecast The TJX Companies Outperform 17
$78.68 Buy/Sell $85.09 8.67%
HUM Stock Forecast Humana Outperform 15
$547.36 Buy/Sell $504.43 13.27%

CVS Health Dividend per Share Forecast for 2022 - 2025 - 2030

In the last three years, CVS Health's Dividend per Share has fallen from $2.00 to $2.00 – a 0.00% decrease. Analysts predict that CVS Health's Dividend per Share will increase in the upcoming year, reaching $2.20. This would represent an increase of 10.00%. Over the next nine years, experts predict that CVS Health's Dividend per Share will grow at a rate of 137.50%.

2022 DPS Forecast
$2.20
2023 DPS Forecast
$2.28
2024 DPS Forecast
$2.48
2025 DPS Forecast
$2.84
2026 DPS Forecast
$3.13
2027 DPS Forecast
$3.47
2028 DPS Forecast
$3.88
2029 DPS Forecast
$4.24
2030 DPS Forecast
$4.75
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
DG Stock Forecast Dollar General Outperform 18
$248.70 Buy/Sell $265.83 10.17%
WBA Stock Forecast Walgreens Boots Alliance Hold 11
$40.90 Buy/Sell $40.85 -2.20%
KR Stock Forecast The Kroger Hold 12
$47.46 Buy/Sell $53.38 11.67%

CVS Health Free Cash Flow Forecast for 2022 - 2025 - 2030

In the last three years, Free Cash Flow for CVS Health has grown by 130.59%, going from $6.83B to $15.75B. According to 5 major analysts, CVS Health's Free Cash Flow will fall by 36.97% in the next year, reaching $9.92B. Professionals believe that By 2030, CVS Health's Free Cash Flow will fall to $13.20B– a 16.16% decrease from its current value.

2022 FCF Forecast
$9.92B
2023 FCF Forecast
$11.42B
2024 FCF Forecast
$11.44B
2025 FCF Forecast
$12.96B
2026 FCF Forecast
$13.48B
2027 FCF Forecast
$11.61B
2028 FCF Forecast
$12.23B
2029 FCF Forecast
$12.58B
2030 FCF Forecast
$13.20B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
DLTR Stock Forecast Dollar Tree Outperform 15
$144.50 Buy/Sell $164.50 16.61%
AD Stock Forecast Koninklijke Ahold Delhaize N.V... Outperform 18
28.43€ Buy/Sell 30.44€ 9.04%
6752 Stock Forecast Panasonic Outperform 17
¥1.23k Buy/Sell ¥0.00 22.35%

CVS Health Net Income Forecast for 2022 - 2025 - 2030

CVS Health's Net Income has seen growth In the last three years, going from $-594.00M to $7.91B – a gain of 1431.65% In the next year, analysts believe that Net Income will reach $10.99B – an increase of 38.93%. For the next nine years, the forecast is forNet Income to grow by 78.91%.

2022 NI Forecast
$10.99B
2023 NI Forecast
$11.80B
2024 NI Forecast
$12.96B
2025 NI Forecast
$14.04B
2026 NI Forecast
$15.40B
2027 NI Forecast
$13.13B
2028 NI Forecast
$13.42B
2029 NI Forecast
$13.87B
2030 NI Forecast
$14.15B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
WSM Stock Forecast Williams-Sonoma Hold 16
$113.27 Buy/Sell $190.37 12.12%
M Stock Forecast Macy's Hold 5
$22.98 Buy/Sell $22.43 8.79%
GPS Stock Forecast The Gap Hold 14
$14.58 Buy/Sell $10.40 -17.70%

CVS Health EBITDA Forecast for 2022 - 2025 - 2030

CVS Health's EBITDA has grown in the last three years, jumping from $12.77B to $18.29B – an increase of 43.23%. In the next year, analysts predict that EBITDA will reach $19.78B – an increase of 8.16%. For the next nine years, the forecast is for EBITDA to grow by 12.41%.

2022 EBITDA Forecast
$19.78B
2023 EBITDA Forecast
$20.67B
2024 EBITDA Forecast
$21.65B
2025 EBITDA Forecast
$20.47B
2026 EBITDA Forecast
$20.26B
2027 EBITDA Forecast
$20.41B
2028 EBITDA Forecast
$20.83B
2029 EBITDA Forecast
$20.71B
2030 EBITDA Forecast
$20.56B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
AHCO Stock Forecast AdaptHealth Buy 14
$22.09 Buy/Sell $0.00 17.70%
MD Stock Forecast MEDNAX Hold 12
$23.02 Buy/Sell $22.33 -4.43%
USNA Stock Forecast USANA Health Sciences Hold 14
$67.46 Buy/Sell $104.00 -15.51%

CVS Health EBIT Forecast for 2022 - 2025 - 2030

In the last three years, CVS Health's EBIT has increased by 37.07%, going from $10.05B to $13.78B. In the next year, analysts are expecting an increase in EBIT, predicting it will reach $16.98B – an increase of 23.23%. The CVS Health forecast is for EBIT to reach $22.65B or grow by 64.41%.

2022 EBIT Forecast
$16.98B
2023 EBIT Forecast
$18.01B
2024 EBIT Forecast
$19.44B
2025 EBIT Forecast
$21.05B
2026 EBIT Forecast
$22.81B
2027 EBIT Forecast
$25.17B
2028 EBIT Forecast
$23.10B
2029 EBIT Forecast
$22.47B
2030 EBIT Forecast
$22.65B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
8086 Stock Forecast Nipro Hold 11
¥1.12k Buy/Sell ¥0.00 -1.35%
NasdaqCM:ATRS Stock Forecast Antares Pharma - 8
$5.59 Buy/Sell $5.60 -6.08%
BKD Stock Forecast Brookdale Senior Living Hold 10
$4.29 Buy/Sell $7.34 86.48%

CVS Health EPS Price Prediction Forecast for 2022 - 2025 - 2030

In the last three years, CVS Health's EPS has grown, moving from $7.08 to $8.40 – an increase of 18.64%. For the next year, 24 analysts project CVS Health's EPS to drop by 1.55%, reaching $8.27. Looking ahead to nine years, experts forecast that EPS will grow by 86.90%.

2022 EPS Forecast
$8.27
2023 EPS Forecast
$8.95
2024 EPS Forecast
$9.93
2025 EPS Forecast
$11.06
2026 EPS Forecast
$12.34
2027 EPS Forecast
$12.77
2028 EPS Forecast
$13.65
2029 EPS Forecast
$14.74
2030 EPS Forecast
$15.70
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BIG Stock Forecast Big Lots Hold 16
$23.03 Buy/Sell $38.89 -2.30%
6376 Stock Forecast Nikkiso Hold 14
¥831.00 Buy/Sell ¥0.00 -3.13%
RAD Stock Forecast Rite Aid Underperform 11
$6.88 Buy/Sell $12.67 1.74%